Peloton Wealth Strategists
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1080132
INDIANAPOLIS, IN
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,609,654
+$528,279 QoQ
Shares Held
9,280
+1.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.45%
of 13F equity value
Holder Rank
#481
of 1,705 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Peloton Wealth Strategists holds $4,942,154 across 2 Biotechnology names. VRTX ranks #1 (93.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9,280 | $4,609,654 | |
| 2 | FDMT |
4D Molecular Therapeutics, Inc.
|
25,000 | $332,500 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,609,654 | 9,280 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,081,375 | 9,140 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,098,374 | 9,040 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,084,165 | 7,875 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,628,380 | 8,150 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,856,258 | 7,954 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,429,891 | 6,034 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,011,549 | 2,175 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $269,514 | 575 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||